 |
selective inhibitor of fungal CYP51 |
|---|---|
| Trade Name | |
| Orphan Indication | Coccidioidomycosis |
| USA Market Approval | USA |
| USA Designation Date | 2016-03-03 00:00:00 |
| Sponsor | Viamet Pharmaceuticals, Inc.;4505 Emperor Boulevard, Suite 300;Durham, North Carolina, 27703 |
| |
selective inhibitor of fungal CYP51 |
|---|---|
| Trade Name | |
| Orphan Indication | Coccidioidomycosis |
| USA Market Approval | USA |
| USA Designation Date | 2016-03-03 00:00:00 |
| Sponsor | Viamet Pharmaceuticals, Inc.;4505 Emperor Boulevard, Suite 300;Durham, North Carolina, 27703 |